β2-Agonists and the Incidence of Parkinson Disease

A recent study found a decreased risk of Parkinson disease (PD) associated with the β2 adrenergic agonist (β2-agonist) salbutamol. However, other mechanisms might explain this apparent association. Using the UK Clinical Practice Research Datalink, we formed a cohort of 2,430,884 patients aged 50 yea...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Am J Epidemiol
Main Authors: Giorgianni, Francesco, Ernst, Pierre, Dell’Aniello, Sophie, Suissa, Samy, Renoux, Christel
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2020
Fag:
Original Contribution
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7407600/
https://ncbi.nlm.nih.gov/pubmed/32016345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwaa012
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker